179 related articles for article (PubMed ID: 35634558)
1. Assessment of endocrine disruptive properties of PFOS: EFSA/ECHA guidance case study utilising AOP networks and alternative methods.
Pípal M; Wiklund L; Caccia S; Beronius A
EFSA J; 2022 May; 20(Suppl 1):e200418. PubMed ID: 35634558
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the endocrine disrupting properties of Bisphenol AF according to the EU criteria and ECHA/EFSA guidance.
; Escrivá L; Hanberg A; Zilliacus J; Beronius A
EFSA J; 2019 Sep; 17(Suppl 2):e170914. PubMed ID: 32626472
[TBL] [Abstract][Full Text] [Related]
3. Exploring a mechanism-based approach for the identification of endocrine disruptors using Adverse Outcome Pathways (AOPs) and New Approach Methodologies (NAMs) : A perfluorooctane sulfonic acid case study.
Wiklund L; Pípal M; Weiss J; Beronius A
Toxicology; 2024 May; 504():153794. PubMed ID: 38580097
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the endocrine disrupting properties of bisphenol AF: a case study applying the European regulatory criteria and guidance.
Escrivá L; Zilliacus J; Hessel E; Beronius A
Environ Health; 2021 Apr; 20(1):48. PubMed ID: 33894771
[TBL] [Abstract][Full Text] [Related]
5. A validated search filter for the identification of endocrine disruptors based on the ECHA/EFSA guidance recommendations.
Escrivá L; Hessel E; Gustafsson S; van Spronsen R; Svanberg M; Beronius A
Environ Int; 2020 Sep; 142():105828. PubMed ID: 32502797
[TBL] [Abstract][Full Text] [Related]
6. Development of a data-driven approach to Adverse Outcome Pathway network generation: a case study on the EATS-modalities.
Wiklund L; Caccia S; Pípal M; Nymark P; Beronius A
Front Toxicol; 2023; 5():1183824. PubMed ID: 37229356
[TBL] [Abstract][Full Text] [Related]
7. Using assessment criteria for pesticides to evaluate the endocrine disrupting potential of non-pesticide chemicals: Case butylparaben.
Boberg J; Johansson HKL; Axelstad M; Olsen GPM; Johansen M; Holmboe SA; Andersson AM; Svingen T
Environ Int; 2020 Nov; 144():105996. PubMed ID: 32771829
[TBL] [Abstract][Full Text] [Related]
8. Assessment of three approaches for regulatory decision making on pesticides with endocrine disrupting properties.
Marx-Stoelting P; Niemann L; Ritz V; Ulbrich B; Gall A; Hirsch-Ernst KI; Pfeil R; Solecki R
Regul Toxicol Pharmacol; 2014 Dec; 70(3):590-604. PubMed ID: 25239592
[TBL] [Abstract][Full Text] [Related]
9. Investigation of a derived adverse outcome pathway (AOP) network for endocrine-mediated perturbations.
Ravichandran J; Karthikeyan BS; Samal A
Sci Total Environ; 2022 Jun; 826():154112. PubMed ID: 35219661
[TBL] [Abstract][Full Text] [Related]
10. The EU endocrine disruptors' regulation and the glyphosate controversy.
Kalofiri P; Balias G; Tekos F
Toxicol Rep; 2021; 8():1193-1199. PubMed ID: 34150528
[TBL] [Abstract][Full Text] [Related]
11. Development of adverse outcome pathways relevant for the identification of substances having endocrine disruption properties Uterine adenocarcinoma as adverse outcome.
; Hernandez-Jerez AF; Adriaanse P; Aldrich A; Berny P; Coja T; Duquesne S; Focks A; Millet M; Pelkonen O; Pieper S; Tiktak A; Topping CJ; Widenfalk A; Wilks M; Wolterink G; Angeli K; Recordati C; Van Durseen M; Aiassa E; Lanzoni A; Lostia A; Martino L; Guajardo IPM; Panzarea M; Terron A; Marinovich M
EFSA J; 2023 Feb; 21(2):e07744. PubMed ID: 36818642
[TBL] [Abstract][Full Text] [Related]
12. COSMOS next generation - A public knowledge base leveraging chemical and biological data to support the regulatory assessment of chemicals.
Yang C; Cronin MTD; Arvidson KB; Bienfait B; Enoch SJ; Heldreth B; Hobocienski B; Muldoon-Jacobs K; Lan Y; Madden JC; Magdziarz T; Marusczyk J; Mostrag A; Nelms M; Neagu D; Przybylak K; Rathman JF; Park J; Richarz AN; Richard AM; Ribeiro JV; Sacher O; Schwab C; Vitcheva V; Volarath P; Worth AP
Comput Toxicol; 2021 Aug; 19():100175. PubMed ID: 34405124
[TBL] [Abstract][Full Text] [Related]
13. Scientific principles for the identification of endocrine-disrupting chemicals: a consensus statement.
Solecki R; Kortenkamp A; Bergman Å; Chahoud I; Degen GH; Dietrich D; Greim H; Håkansson H; Hass U; Husoy T; Jacobs M; Jobling S; Mantovani A; Marx-Stoelting P; Piersma A; Ritz V; Slama R; Stahlmann R; van den Berg M; Zoeller RT; Boobis AR
Arch Toxicol; 2017 Feb; 91(2):1001-1006. PubMed ID: 27714423
[TBL] [Abstract][Full Text] [Related]
14. A plea for risk assessment of endocrine disrupting chemicals.
Testai E; Galli CL; Dekant W; Marinovich M; Piersma AH; Sharpe RM
Toxicology; 2013 Dec; 314(1):51-9. PubMed ID: 23939142
[TBL] [Abstract][Full Text] [Related]
15. Integrative Strategy of Testing Systems for Identification of Endocrine Disruptors Inducing Metabolic Disorders-An Introduction to the OBERON Project.
Audouze K; Sarigiannis D; Alonso-Magdalena P; Brochot C; Casas M; Vrijheid M; Babin PJ; Karakitsios S; Coumoul X; Barouki R
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340264
[TBL] [Abstract][Full Text] [Related]
16. The EDCMET Project: Metabolic Effects of Endocrine Disruptors.
Küblbeck J; Vuorio T; Niskanen J; Fortino V; Braeuning A; Abass K; Rautio A; Hakkola J; Honkakoski P; Levonen AL
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32344727
[TBL] [Abstract][Full Text] [Related]
17. Risk assessment of 'endocrine substances': guidance on identifying endocrine disruptors.
Lewis RW
Toxicol Lett; 2013 Dec; 223(3):287-90. PubMed ID: 24036001
[TBL] [Abstract][Full Text] [Related]
18. Endocrine disruptors also function as nervous disruptors and can be renamed endocrine and nervous disruptors (ENDs).
Seralini GE; Jungers G
Toxicol Rep; 2021; 8():1538-1557. PubMed ID: 34430217
[TBL] [Abstract][Full Text] [Related]
19. Weight of evidence approaches for the identification of endocrine disrupting properties of chemicals: Review and recommendations for EU regulatory application.
Gross M; Green RM; Weltje L; Wheeler JR
Regul Toxicol Pharmacol; 2017 Dec; 91():20-28. PubMed ID: 28986177
[TBL] [Abstract][Full Text] [Related]
20. European Union's strategy on endocrine disrupting chemicals and the current position of Slovenia.
Perharič L; Fatur T; Drofenik J
Arh Hig Rada Toksikol; 2016 Jun; 67(2):99-105. PubMed ID: 27331297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
